Ingredient · Evidence grade C

Black cohosh for menopause: evidence, studies and safety

Last updated · 14 studies summarized

C Short answer: Black cohosh is the most-studied herb for occasional hot flashes and night sweats associated with menopause*. Independent trials and a Cochrane review found no clear benefit over placebo, other reviews found a small one, and rare liver-injury reports exist.

Key facts

Evidence gradeC C (iCR extract specifically: C+)
Use studiedhot flashes / menopausal symptoms
Trials≥16 RCTs in Cochrane 2012; 22 articles in Sadahiro 2023 MA
Participants~2,000–2,300 in RCT meta-analyses (manufacturer review counts 43,759 incl. observational)
What reviews concludeCochrane 2012 (16 RCTs, 2,027 women): no difference vs placebo for hot-flush frequency. Sadahiro 2023 MA: small-moderate benefit (g 0.32 hot flashes). Manufacturer-affiliated iCR MA (2021): positive, dose-dependent. Large independent US trials (HALT 2006, Geller 2009, Pockaj 2006) null. IMS 2026 review: moderate certainty for benefit.
The Menopause Society (2023)Not recommended (Level I) – 'insufficient evidence to support use for VMS'.
Also known asRemifemin, iCR, Cimicifuga

Grades: A strong · B moderate · C limited · D none or negative. How we grade.

Every study we reviewed

Each summary gives who took part, the dose, how long, the result compared with placebo or control, and who paid for it.

  • Black cohosh (Cimicifuga spp.) for menopausal symptoms.

    Leach MJ, Moore V · Cochrane Database Syst Rev 2012 · Black cohosh

    An independent Cochrane review pooled 16 trials with about 2,000 women taking black cohosh (usually 40 mg a day for around 5 months). Women taking black cohosh did not have fewer hot flashes than women on a dummy pill, and the reviewers called the safety data inconclusive.

    Who
    16 RCTs, 2,027 women
    Dose
    median 40 mg/day black cohosh extract
    Duration
    mean 23 weeks
    Result
    No difference vs placebo in hot-flush frequency (MD +0.07/day; 95% CI -0.43 to 0.56; 3 trials, 393 women) or symptom scores; hormone therapy beat black cohosh.
    Funding
    Cochrane review (independent). Independent / academic

    PubMed · Full text (DOI)

  • Black cohosh extracts in women with menopausal symptoms: an updated pairwise meta-analysis.

    Sadahiro R, Matsuoka LN, Zeng BS et al. · Menopause 2023 · Black cohosh

    A 2023 analysis of 22 studies (about 2,300 women) found black cohosh extracts did somewhat better than placebo for overall menopause symptoms and hot flashes, with a small-to-moderate effect. It did not help anxiety or low mood, and the studies varied a lot in product and quality.

    Who
    22 articles, 2,310 women
    Dose
    various black cohosh extracts
    Duration
    various
    Result
    Pooled improvement vs placebo in overall menopausal symptoms (Hedges g 0.58) and hot flashes (g 0.32); no significant effect on anxiety or depression.
    Funding
    Academic; one author reported speaker fees from supplement/pharma companies incl. Cimic. Some author ties

    PubMed · Full text (DOI)

  • Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms - an update on the evidence.

    Castelo-Branco C, Gambacciani M, Cano A et al. · Climacteric 2021 · Black cohosh, St John's wort + black cohosh

    This review looked only at the specific black cohosh extract in Remifemin and found it beat placebo for menopause symptoms, especially at higher doses or combined with St John's wort. Several authors work for the company that makes Remifemin, so read it as a manufacturer-backed summary.

    Who
    35 studies + 1 MA, 43,759 women (13,096 on iCR)
    Dose
    isopropanolic extract (iCR, Remifemin), 20–>40 mg/day
    Duration
    various
    Result
    SMD -0.69 vs placebo for neurovegetative/psychological symptoms; larger effect at higher dose and with St John's wort; no hepatotoxicity signal in trial data.
    Funding
    Co-authored by staff of Schaper & Brümmer (maker of Remifemin) – manufacturer-affiliated. Industry-linked

    PubMed · Full text (DOI)

  • Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms.

    Osmers R, Friede M, Liske E et al. · Obstet Gynecol 2005 · Black cohosh

    About 300 women with menopause symptoms took Remifemin-type black cohosh (40 mg a day) or a dummy pill for 12 weeks. Symptom scores improved more with black cohosh, mostly in women early in menopause, and side effects were similar to placebo.

    Who
    304 women
    Dose
    iCR (Remifemin) equivalent to 40 mg root/day
    Duration
    12 weeks
    Result
    More effective than placebo on the Menopause Rating Scale (P<.001), mainly in early menopause; hot-flush subscore was the most responsive.
    Funding
    Funding not stated in the abstract (study of the manufacturer's extract). Funding not stated

    PubMed · Full text (DOI)

  • Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1.

    Pockaj BA, Gallagher JG, Loprinzi CL et al. · J Clin Oncol 2006 · Black cohosh

    In a publicly funded US trial, 132 women took black cohosh (20 mg twice a day) or placebo for 4 weeks each. Hot flashes dropped slightly more on placebo than on black cohosh, so the trial found no benefit.

    Who
    132 women (history of or concern about breast cancer; crossover)
    Dose
    black cohosh 20 mg twice daily
    Duration
    two 4-week periods (crossover)
    Result
    Hot-flash frequency fell 17% on black cohosh vs 26% on placebo (P=.36) – no benefit.
    Funding
    NCCTG/NCI cooperative group (public funding). Independent / academic

    PubMed · Full text (DOI)

  • Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial.

    Newton KM, Reed SD, LaCroix AZ et al. · Ann Intern Med 2006 · Black cohosh, Soy isoflavones & genistein

    The US government-funded HALT study followed 351 women for a year. Black cohosh (160 mg a day), a 10-herb blend, and the blend plus more soy food did no better than a dummy pill for hot flashes, while hormone therapy clearly worked.

    Who
    351 women aged 45–55
    Dose
    black cohosh 160 mg/day; multibotanical; multibotanical + soy diet; hormone therapy; placebo
    Duration
    12 months
    Result
    No herbal arm differed from placebo at 3, 6 or 12 months (<1 hot flash/day difference); hormone therapy reduced ~4 symptoms/day vs placebo.
    Funding
    US NIH (NCCAM/NIA) – HALT study, independent. Independent / academic

    PubMed · Full text (DOI)

  • Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial.

    Geller SE, Shulman LP, van Breemen RB et al. · Menopause 2009 · Black cohosh, Red clover

    In a year-long, government-funded trial, women took black cohosh, red clover, hormone therapy or a dummy pill. Only hormones beat placebo for hot flashes; both herbs looked safe but did not reduce hot flashes more than placebo.

    Who
    89 women (4 arms)
    Dose
    standardized black cohosh and red clover extracts vs CEE/MPA vs placebo
    Duration
    12 months
    Result
    Hot-flash reduction: black cohosh 34%, red clover 57%, placebo 63%, hormones 94%; neither botanical beat placebo. Both appeared safe over 12 months.
    Funding
    NIH (NCCAM/ODS) botanical center, University of Illinois – independent. Independent / academic

    PubMed · Full text (DOI)

  • Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial.

    Frei-Kleiner S, Schaffner W, Rahlfs VW et al. · Maturitas 2005 · Black cohosh

    122 women took a different (ethanol-based) black cohosh extract or placebo for 12 weeks. Overall it did not beat placebo; only women with more severe symptoms seemed to benefit, which is a weaker, after-the-fact finding.

    Who
    122 women with ≥3 hot flashes/day
    Dose
    dried ethanolic black cohosh extract (non-Remifemin)
    Duration
    12 weeks
    Result
    No superiority over placebo overall; benefit only in subgroup with moderate–severe symptoms (Kupperman ≥20: -47% vs -21%).
    Funding
    Not stated in abstract. Funding not stated

    PubMed · Full text (DOI)

  • Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract.

    Naser B, Schnitker J, Minkin MJ et al. · Menopause 2011 · Black cohosh

    This analysis of 5 trials found no change in liver blood tests in women taking the Remifemin extract for up to 6 months. It was written by the manufacturer and covers only short-term use.

    Who
    5 RCTs, 1,117 women
    Dose
    iCR 40–128 mg/day
    Duration
    3–6 months
    Result
    No effect on liver enzymes (AST/ALT) vs reference groups.
    Funding
    Written by Schaper & Brümmer (Remifemin maker) staff. Industry-linked

    PubMed · Full text (DOI)

  • United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity.

    Mahady GB, Low Dog T, Barrett ML et al. · Menopause 2008 · Black cohosh

    The US Pharmacopeia reviewed 30 reports of liver injury in people using black cohosh. It could not prove black cohosh caused them but recommended a label warning to stop and see a doctor if liver symptoms appear.

    Who
    30 case reports of liver damage
    Dose
    various products
    Duration
    n/a
    Result
    All 30 liver cases rated 'possible' (none probable/certain); USP recommended a cautionary liver label.
    Funding
    US Pharmacopeia expert committee (independent standard-setter). Independent / academic

    PubMed · Full text (DOI)

  • Black cohosh and breast cancer: a systematic review.

    Fritz H, Seely D, McGowan J et al. · Integr Cancer Ther 2014 · Black cohosh

    A systematic review of black cohosh and breast cancer found no sign it increases breast-cancer risk, but also no proof it reduces hot flashes in women who have had breast cancer.

    Who
    26 studies (14 RCTs)
    Dose
    various
    Duration
    various
    Result
    No evidence black cohosh raises breast-cancer risk; no proven hot-flash benefit in breast-cancer patients vs placebo.
    Funding
    Academic (Canadian naturopathic/academic group). Independent / academic

    PubMed · Full text (DOI)

  • Actaea racemosa L. Is More Effective in Combination with Rhodiola rosea L. for Relief of Menopausal Symptoms: A Randomized, Double-Blind, Placebo-Controlled Study.

    Pkhaladze L, Davidova N, Khomasuridze A et al. · Pharmaceuticals (Basel) 2020 · Black cohosh, Rhodiola

    220 women in Georgia took black cohosh alone, black cohosh plus Rhodiola, or placebo for 12 weeks; the combination worked best. An author is paid by the company that sells the combination.

    Who
    220 women
    Dose
    black cohosh 6.5 mg; black cohosh 500 mg; Rhodiola+black cohosh (Menopause Relief EP); placebo
    Duration
    12 weeks
    Result
    Rhodiola+black cohosh beat black cohosh alone and placebo on all symptom scales.
    Funding
    Author has contract with Europharma USA (seller) and heads Phytomed AB. Industry-linked

    PubMed · Full text (DOI)

  • Complementary therapies for management of menopausal symptoms: a systematic review to inform the update of the International Menopause Society recommendations on women's midlife health.

    Maunder A, Mardon AK, Rao V et al. · Climacteric 2026 · Black cohosh, Vitamin D & calcium

    A 2026 International Menopause Society evidence review rated black cohosh's benefit for hot flashes as moderate-certainty and most other supplements as low-certainty.

    Who
    158 studies
    Dose
    various
    Duration
    n/a
    Result
    Moderate-certainty evidence supports black cohosh for vasomotor/menopausal symptoms and vitamin D for fracture risk; most complementary therapies low/very-low certainty.
    Funding
    International Menopause Society review. Independent / academic

    PubMed · Full text (DOI)

  • Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone.

    Bai W, Henneicke-von Zepelin HH, Wang S et al. · Maturitas 2007 · Black cohosh

    244 Chinese women took Remifemin-type black cohosh or the hormone-like drug tibolone for 12 weeks. Symptom scores fell similarly in both groups, but there was no placebo group, so the size of the true effect is unclear.

    Who
    244 Chinese women
    Dose
    iCR (Remifemin) equivalent to 40 mg/day vs tibolone 2.5 mg/day (no placebo)
    Duration
    12 weeks
    Result
    Kupperman Index fell similarly with iCR and tibolone; iCR better tolerated.
    Funding
    Not stated in abstract. Funding not stated

    PubMed · Full text (DOI)

Safety

Rare liver injury reports (USP: 30 cases 'possible' causality; ODS: ≥83 cases worldwide, causality unproven). USP-recommended label: discontinue if liver disorder or symptoms of liver trouble. No evidence of increased breast-cancer risk (Fritz 2014), but safety after breast cancer not established (NCCIH). Possible interaction with statins (NCCIH).

Ranked products that contain it

Ranked products containing Black cohosh, by our score.
ProductAmount per dayScore$/day
Remifemin Menopause ReliefBlack cohosh extract (iCR): 40 mg61.8$0.50
Estroven Menopause Relief + Weight ManagementBlack cohosh root extract: 40 mg58.4$0.63
Nature's Way Black Cohosh Premium ExtractBlack cohosh root/rhizome extract, standardized 2.5% triterpene glycosides: 80 mg51.5$0.42
O Positiv MENO Menopause GummiesBlack cohosh root extract: 40 mg50.8$1.40
Gaia Herbs Menopause Support DaytimeOrganic black cohosh root extract: 600 mg40.2$1.53

FAQ

Does Black cohosh help with menopause symptoms?

Black cohosh is the most-studied herb for occasional hot flashes and night sweats associated with menopause*. Independent trials and a Cochrane review found no clear benefit over placebo, other reviews found a small one, and rare liver-injury reports exist. Our evidence grade is C (iCR extract specifically: C+). Cochrane 2012 (16 RCTs, 2,027 women): no difference vs placebo for hot-flush frequency. Sadahiro 2023 MA: small-moderate benefit (g 0.32 hot flashes). Manufacturer-affiliated iCR MA (2021): positive, dose-dependent. Large independent US trials (HALT 2006, Geller 2009, Pockaj 2006) null. IMS 2026 review: moderate certainty for benefit.

Does The Menopause Society recommend Black cohosh?

Not recommended (Level I) – 'insufficient evidence to support use for VMS'. The 2023 nonhormone statement recommends no dietary supplement for hot flashes; talk to a clinician about hormone therapy and prescription options.

Is Black cohosh safe?

Rare liver injury reports (USP: 30 cases 'possible' causality; ODS: ≥83 cases worldwide, causality unproven). USP-recommended label: discontinue if liver disorder or symptoms of liver trouble. No evidence of increased breast-cancer risk (Fritz 2014), but safety after breast cancer not established (NCCIH). Possible interaction with statins (NCCIH). Supplements are not FDA-approved before sale; ask a clinician or pharmacist, especially if you take medication.

Sources

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Solynes does not sell supplements; descriptions summarize published research and are not medical advice.